Izun Pharmaceuticals
Pharmaceuticals
Multinational United States Est. 2000
Team
1
1-10 employees
Confidence
57/100
News
1
articles
About
Izun Pharmaceuticals Corporation focuses on natural solutions in the area of periodontal inflammation. Izuns products are both efficacious and safe, providing novel solutions with the potential to capitalize on multi-billion-dollar market opportunities. Izun Pharma Ltd is a wholly-owned Jerusalem-based R&D subsidiary. A proprietary, botanically-based platform technology was developed which helps treat a wide range of inflammatory diseases, while simultaneously accelerating the bodys natural tissue repair processes.
Classification
Tags
tissue-regenerationinflammatory-diseasestopical-treatmentpharmaceuticals
News (1)
Oct 11, 2017 · www.businesswire.com
Izun Pharmaceuticals Announces Positive Results from Phase 2 Double Blind Oral Mucositis Trial
Details
Employees
1-10
Exact Count
6
Founded
2000
Locations
Kiryat HaMada 5, Jerusalem, Israel
1 Rockefeller Plaza, New York, NY 10020, USA
Links
Admin
Last Update
Apr 17, 2019
Verified by
Yamila Silbert
Missing
funding stage, product stage, sector, founding month, business model, video or image, funding rounds, markets, not claimed
Team (1)
William Levine
Founder & Chief Scientific Officer
Founder
Internal
Created by
Yanina Wainscheinker (yanina.wain@gmail.com)
Created
2019-04-03T00:00:00.000Z
Last editor
Maor Perlov (maor.perlov@sncentral.org)
Recent activity
Maor Perlov · Manual · 2022-11-29 07:23:56.000000
Maor Perlov · Manual · 2022-11-29 07:24:19.000000
Maor Perlov · Manual · 2022-11-29 07:23:56.000000
Maor Perlov · Manual · 2022-11-29 07:23:56.000000
Maor Perlov · Manual · 2022-11-29 07:23:56.000000
Marina Badyaeva · Automatic · 2023-03-26 08:01:44.000000
Maor Perlov · Manual · 2022-11-29 07:25:45.000000
Yamila Silbert · Manual · 2019-04-17 05:25:18.000000
Yanina Wainscheinker · Manual · 2019-04-03 22:36:07.000000
Yanina Wainscheinker · Manual · 2019-04-03 22:10:29.000000